870341 | 18:1 PE (DOPE) pSar25
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-polysarcosine-25 (ammonium salt)
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
18:1 PE (DOPE) pSar25
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-polysarcosine-25 (ammonium salt)
Polymers are a common modification made to lipids used for liposomal and lipid nanoparticle delivery systems. Adding a polymer-conjugated lipid to a formulation can improve several properties of the drug delivery system. Polyethyleneglycol (PEG) has historically been the most common polymer used in clinical practice. But recent studies have shown polysarcosine polymer-conjugated lipids to have similar stealth properties as PEG-conjugated lipids, but with the added bonus of an improved safety profile. Use 18:1 PE (DOPE) pSar25 as an alternative to 18:1 PE (DOPE) PEG2000 in your lipid formulations research today!
The molecular weight and exact mass are averages based on the polydispersity of PEG.
Polysarcosine-liposome formulations for mRNA delivery targeting the brain
C130H231N28O35P
C 56.22%, H 8.38%, N 14.12%, O 20.16%, P 1.12%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by Bioz- Certificate of Analysis (Lot No. 870341P-25MG-A-010 and 7102PJA010)
- Certificate of Analysis (Lot No. 870341P-25MG-B-010 and 7102PJB010)
